GUARDANT HEALTH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 705.70K shares, a 1097.89% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 111.33K shares, a 152.33% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 406.78K shares, a 1352.80% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 117.51K shares, a 2736.30% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 627.33K shares, a 2.93% increase from fiscal 2024.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 609.50K shares, a 1092.19% increase from fiscal 2023.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 51.12K shares, a 77.61% decline from fiscal 2022.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 228.31K shares, a 67.06% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 705.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | 1.34M shares derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 111.33K shares 10-Q · filed 2026-05-07 | 694.53K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 406.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 627.33K shares 10-K · filed 2026-02-19 |
| 2025-09-30 | 117.51K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | 248.54K shares derived: sum of 4 quarters · filed 2026-02-19 |
| 2025-06-30 | 58.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | 135.18K shares derived: sum of 4 quarters · filed 2026-02-19 |
| 2025-03-31 | 44.12K shares 10-Q · filed 2025-04-30 | 616.83K shares derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-12-31 | 28.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 609.50K shares 10-K · filed 2026-02-19 |
| 2024-09-30 | 4.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 591.75K shares derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | 540.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 596.60K shares derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | 36.79K shares 10-Q · filed 2024-05-09 | 66.87K shares derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | 10.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 51.12K shares 10-K · filed 2026-02-19 |
| 2023-09-30 | 8.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 61.83K shares derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | 10.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 104.17K shares derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | 21.05K shares 10-Q · filed 2023-05-09 | 144.14K shares derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | 20.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | 228.31K shares 10-K · filed 2025-02-20 |
| 2022-09-30 | 51.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 271.18K shares derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | 50.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 477.38K shares derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | 105.22K shares 10-Q · filed 2022-05-05 | 515.41K shares derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | 63.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 693.07K shares 10-K · filed 2024-02-22 |
| 2021-09-30 | 257.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 887.57K shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | 88.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 1.16M shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | 282.88K shares 10-Q · filed 2021-05-06 | 1.49M shares derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | 258.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 1.45M shares 10-K · filed 2023-02-23 |
| 2020-09-30 | 533.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 1.56M shares derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | 412.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 1.98M shares derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | 242.00K shares 10-Q · filed 2020-05-07 | 3.10M shares derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | 371.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 3.00M shares 10-K · filed 2022-02-24 |
| 2019-09-30 | 949.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 2.77M shares derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | 1.53M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | |
| 2019-03-31 | 146.32K shares 10-Q · filed 2019-05-10 | |
| 2018-12-31 | 142.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 1.01M shares 10-K · filed 2021-02-25 |
| 2016-12-31 | 342.95K shares 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |